Value investing is always a very popular strategy, and for good reason. After all, who doesn’t want to find stocks that have low PEs, solid outlooks, and decent dividends?
Fortunately for investors looking for this combination, we have identified a strong candidate which may be an impressive value; MetLife, Inc. MET.
MetLife in Focus
MET may be an interesting play thanks to its forward PE of 8.6, its P/S ratio of 0.7, and its decent dividend yield of 3.7%. These factors suggest that MetLife is a pretty good value pick, as investors have to pay a relatively low level for each dollar of earnings, and that MET has decent revenue metrics to back up its earnings.
MetLife, Inc. PE Ratio (TTM)
MetLife, Inc. pe-ratio-ttm | MetLife, Inc. Quote
But before you think that MetLife is just a pure value play, it is important to note that it has been seeing solid activity on the earnings estimate front as well. For current year earnings, the consensus has gone up by 2.4% in the past 60 days, thanks to five upward revisions in the past two months compared to none lower.
This estimate strength is actually enough to push MET to a Zacks Rank #2 (Buy), suggesting it is poised to outperform. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
So really, MetLife is looking great from a number of angles thanks to its PE below 20, a P/S ratio below one, and a strong Zacks Rank, meaning that this company could be a great choice for value investors at this time.
Looking for Stocks with Skyrocketing Upside?
Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.
Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.
See the pot trades we're targeting>>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
MetLife, Inc. (MET) : Free Stock Analysis Report
To read this article on Zacks.com click here.